Clinical Pilates (CP) Exercises and Kinesiophobia in CABG
Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 19, 2024
Trial Information
Current as of February 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of Clinical Pilates exercises on patients who have recently undergone coronary artery bypass grafting (CABG) surgery. Specifically, it aims to see how these exercises can help reduce kinesiophobia, which is a fear of movement that can make patients hesitant to participate in rehabilitation. When patients avoid exercise due to this fear, it can lead to further health issues like depression and decreased mobility. By including Pilates in their recovery, the study hopes to improve both the psychological and physical recovery of these patients.
To be eligible for this trial, participants should be stable patients who have had elective CABG surgery and have been diagnosed with kinesiophobia using a specific scale. However, those with certain conditions affecting their ability to move, such as severe liver or kidney disease, or those needing significant assistance, cannot participate. Individuals who join the trial can expect to engage in Pilates exercises as part of their cardiac rehabilitation, with the goal of helping them feel more comfortable and confident in their ability to move and recover.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemodynamically stable patient Who underwent elective CABG.
- • Patients diagnosed with Kinesiophobia via Tampa scale for Kinesiophobia Heart (TSK-SV Heart)
- Exclusion Criteria:
- • Neuromuscular conditions which lead to kinesiophobia
- • Diseases that seriously affected the functional capacity or mobility such as liver cirrhosis, chronic renal failure and disabled patients.
- • Prolong intubation
- • Vital instability
- • Patients needing maximum assistance
- • Decline consent
Trial Officials
Mehwish Waseem, MSPT-CPPT
Principal Investigator
Riphah International University
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0